Scientific strategy & risk-based optimisation
Regulators increasingly expect scientific justification and risk-based approaches to analytical testing and validation programs. Over-testing increases cost and complexity, while under-testing risks non-compliance. Our scientific consulting services optimise analytical strategies, reduce unnecessary studies, and prepare risk–benefit documentation aligned with regulatory expectations.
We help pharmaceutical and biotech companies balance efficiency, compliance, and inspection readiness.
Development of regulatory-aligned analytical strategies based on scientific risk assessment according to ICH Q9.
Study optimisation and reduction
Optimisation and reduction of testing programs through risk-based justification.
Risk–benefit documentation for regulators
Preparation of structured scientific justification documents supporting regulatory dialogue.